TABLE 5:

Review of the literature

ReferenceDeviceTotal ComplicationsHematomasArteriovenous FistulasPseudoaneurysms
DeviceControlDeviceControlDeviceControlDeviceControl
9 (Tron et al, 1998)Perclose Techstar5/82 (6.1)2/67 (3.0)5/82 (6.1)2/67 (3.0)0/82 (0)0/67 (0)0/82 (0)0/67 (0)
10 (Gerckens et al, 1999)Perclose Techstar12/298 (4.0)22/292 (7.5)11/298 (3.7)21/292 (7.2)0/298 (0)0/292 (0)1/298 (0.3)1/292 (0.3)
11 (El Amine et al, 1999)Perclose Techstar6/50 (12.0)4/50 (8.0)5/50 (10.0)4/50 (8.0)0/50 (0)0/50 (0)1/50 (2.0)0/50 (0)
12 (Baim et al, 2000)Perclose Techstar8/251 (3.2)6/264 (2.3)6/251 (2.4)3/264 (1.1)0/251 (0)0/264 (0)2/251 (0.8)3/264 (1.1)
13 (Noguchi et al, 2000)Perclose Techstar4/30 (13.3)10/30 (33.3)4/30 (13.3)10/30 (33.3)0/30 (0)0/30 (0)0/30 (0)0/30 (0)
14 (Rindner et al, 2001)Perclose Techstar134/880 (15.2)215/874 (24.6)40/880 (4.5)55/874 (6.3)2/880 (0.2)6/874 (0.7)7/880 (0.8)16/874 (1.8)
15 (Duffin et al, 2001)Perclose Techstar, Angioseal31/280 (11.1)12/197 (6.1)25/280 (8.9)7/197 (3.6)0/280 (0)0/197 (0)0/280 (0)0/197 (0)
18 (Hahn et al, 2001)Perclose Closer S2/22 (9.1)NA2/22 (9.1)NA0/22 (0)NA0/22 (0)NA
16 (Kahn et al, 2002)Perclose Closer Plus145/1420 (10.2)356/8581 (4.1)73/1420 (5.1)255/8581 (3.0)0/1420 (0)0/8581 (0)26/1420 (1.8)25/8581 (0.3)
17 (Rickli et al, 2002)Perclose Techstar8/96 (8.3)6/97 (6.2)7/96 (7.3)5/97 (5.2)0/96 (0)0/97 (0)1/96 (1.0)1/97 (1.0)
4 (Assali et al, 2003)Perclose Techstar, Angioseal18/123 (14.6)13/123 (10.6)15/123 (12.2)12/123 (9.8)0/123 (0)0/123 (0)1/123 (0.8)0/123 (0)
19 (Henk et al, 2003)Perclose Closer S41/117 (32.0)NA19/117 (16.2)NA0/117 (0)NA1/117 (0.8)NA
Present studyPerclose Closer S3/475 (0.6)2/79 (2.5)NANA0/475 (0)0/791/475 (0.2)2/79 (2.5)
  • Note.—Data in parentheses are percentages. NA = not applicable.